PolyProx Therapeutics is a biotechnology company
PolyProx Therapeutics has raised €4.0M across 1 funding round from 3 investors, most recently a Seed round in Apr 2019. Based in Cambridge, UK; founded 2019; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-04-01 | Seed | €4.0M |
| Cambridge Innovation Capital,Rt Capital Management,University of Cambridge Enterprise |
| View deal → |
